Matt has a broad-ranging corporate practice focused primarily on private equity and growth equity transactions and portfolio companies, strategic M&A, and corporate governance. Clients turn to Matt for his varied industry knowledge and experience in working with companies of all sizes.

Overview
Representative Matters
Insights
Awards

Matt is a member of the firm’s Executive Committee. His practice is focused on representing private equity funds, growth equity funds, and their portfolio companies in their major transactions including mergers, acquisitions and sales. He also represents buyers and sellers in transactions involving both publicly traded and privately held businesses, subsidiaries and divisions of public companies, and has experience in roll-up, and corporate carve-out and distressed transactions. Matt has also represented clients in connection with asset sales and acquisitions in bankruptcy proceedings.

Clients also turn to Matt for counseling in connection with capital raising transactions and throughout their lifecycle on governance and commercial matters.

Matt counsels clients in a variety of industries such as technology, health care, life sciences, consumer goods, gaming, industrials, transportation, and distribution.

Matt has significant experience in Delaware corporate and alternative entity law. He advises boards of directors and special committees on fiduciary duties and corporate governance matters related to Delaware corporations, limited partnerships and limited liability companies, including in connection with potential merger and financing transactions and conflict of interest situations. He regularly provides legal opinions under Delaware law and counsels public companies in ongoing reporting and compliance matters.

  • Represented numerous private equity and venture capital funds (including Small Business Investment Companies (SBICs)) in connection with their investments:
    • a private equity firm in connection with its $1 billion auction of a health care industry portfolio company.
    • a private equity fund in its acquisition of a designer, marketer and distributor of consumer brand products.
    • a venture capital fund in connection with its sale of an Internet software portfolio company to a NYSE company.
    • a private equity fund with its acquisition of several technology solutions portfolio companies.
    • a private equity fund with its investments in several luxury brand portfolio companies.
    • a private equity fund in its platform acquisition of a security guard business.
    • a venture capital fund in connection with its preferred stock investment in an Internet marketplace.
    • a private equity fund in connection with its sale of a manufacturing business to another private equity fund.
    • a private equity fund in connection with its acquisition of the nation’s leading manufacturer and supplier of residential impact-resistant windows and doors, as well as one of the largest window and door manufacturers in the nation.
  • Represented a health care company in several acquisitions of technology businesses.
  • Represented a Nasdaq company in connection with its acquisition of a private equity portfolio company and the refinancing of its indebtedness.
  • Represented a special committee of a Nasdaq company in connection with a share repurchase transaction from its private equity majority stockholder.
  • Represented a group purchasing services company in the health care area with numerous “add-on” acquisitions.
  • Represented a privately held global corporate solutions provider in its acquisition of several technology businesses, including a patent and IT solutions business, an Internet domain business, and a nationwide due diligence and document retrieval business.
  • Represented a leading biofuel supply chain company in connection with several financing and commercial transactions.
  • Represented a privately held health care technology company in its sale to a publicly traded company.
  • Represented a privately held manufacturing company in a management buyout.
  • Represented several investment banks in connection with the issuance of fairness, solvency, and other opinions, and related disclosure issues.
  • Represented numerous early stage and developing companies in connection with angel venture capital and private equity funding.
  • Advised angel investors in connection with various debt and equity financings.
  • Represented a telemedicine company in its financing and negotiation of license agreements.
  • Represented a real estate fund in connection with its formation and investments in several properties.
  • Represented a gaming and entertainment company in connection with its private placement financing, corporate governance matters, sale to a publicly traded U.K. company and subsequent growth transactions in the U.S.
  • Advised several French corporations in their U.S. operations, including their entry into the U.S. market.
  • Represented a publicly traded Canadian company in connection with several U.S. acquisitions.
  • Represented an Indian company in connection with its acquisition from a private equity fund of a life science company.
  • Represented a NYSE-listed company in its acquisition of one of the world’s leading car rental brands and a global travel technology solutions company.
  • Represented a privately held consumer products company in its acquisition by a NYSE-listed company.
  • Represented a privately held energy company in the sale of its gas recovery operations to quasi-governmental entity.
  • Represented a retail electronics chain in its sale to a private equity fund in an asset sale under Section 363 of the Bankruptcy Code.
  • Represented several boards of directors, audit committees, and compensation committees in connection with their SEC, NYSE, and Nasdaq reporting and compliance matters, including the restatement of annual reports on Form 10-K and the preparation of proxy materials.
  • Represented a health care company in the restructuring of $2.6 billion of its publicly traded debt.
  • Represented an electronic media company in a public offering of its securities listed on the Nasdaq.
  • Rated AV Preeminent by Martindale-Hubbell®
  • Best Lawyers in America®: Corporate Law (2016-2026)
  • Chambers USA: Corporate/M&A, Delaware (2016-2025)
  • Legal 500 United States for M&A/Corporate and Commercial: M&A: Middle-Market (Sub-$500M) (2022-2024) and Leading Lawyer (2025); M&A/Corporate and Commercial: Private Equity Buyouts: Middle-Market (Up to $500M) (2024-2025); and Finance: Capital Markets: Debt Offerings (2025)
  • Business Today: Top 10 Corporate/M&A Lawyers in Delaware (2023)

Matt is a member of the firm’s Executive Committee. His practice is focused on representing private equity funds, growth equity funds, and their portfolio companies in their major transactions including mergers, acquisitions and sales. He also represents buyers and sellers in transactions involving both publicly traded and privately held businesses, subsidiaries and divisions of public companies, and has experience in roll-up, and corporate carve-out and distressed transactions. Matt has also represented clients in connection with asset sales and acquisitions in bankruptcy proceedings.

Clients also turn to Matt for counseling in connection with capital raising transactions and throughout their lifecycle on governance and commercial matters.

Matt counsels clients in a variety of industries such as technology, health care, life sciences, consumer goods, gaming, industrials, transportation, and distribution.

Matt has significant experience in Delaware corporate and alternative entity law. He advises boards of directors and special committees on fiduciary duties and corporate governance matters related to Delaware corporations, limited partnerships and limited liability companies, including in connection with potential merger and financing transactions and conflict of interest situations. He regularly provides legal opinions under Delaware law and counsels public companies in ongoing reporting and compliance matters.

  • Represented numerous private equity and venture capital funds (including Small Business Investment Companies (SBICs)) in connection with their investments:
    • a private equity firm in connection with its $1 billion auction of a health care industry portfolio company.
    • a private equity fund in its acquisition of a designer, marketer and distributor of consumer brand products.
    • a venture capital fund in connection with its sale of an Internet software portfolio company to a NYSE company.
    • a private equity fund with its acquisition of several technology solutions portfolio companies.
    • a private equity fund with its investments in several luxury brand portfolio companies.
    • a private equity fund in its platform acquisition of a security guard business.
    • a venture capital fund in connection with its preferred stock investment in an Internet marketplace.
    • a private equity fund in connection with its sale of a manufacturing business to another private equity fund.
    • a private equity fund in connection with its acquisition of the nation’s leading manufacturer and supplier of residential impact-resistant windows and doors, as well as one of the largest window and door manufacturers in the nation.
  • Represented a health care company in several acquisitions of technology businesses.
  • Represented a Nasdaq company in connection with its acquisition of a private equity portfolio company and the refinancing of its indebtedness.
  • Represented a special committee of a Nasdaq company in connection with a share repurchase transaction from its private equity majority stockholder.
  • Represented a group purchasing services company in the health care area with numerous “add-on” acquisitions.
  • Represented a privately held global corporate solutions provider in its acquisition of several technology businesses, including a patent and IT solutions business, an Internet domain business, and a nationwide due diligence and document retrieval business.
  • Represented a leading biofuel supply chain company in connection with several financing and commercial transactions.
  • Represented a privately held health care technology company in its sale to a publicly traded company.
  • Represented a privately held manufacturing company in a management buyout.
  • Represented several investment banks in connection with the issuance of fairness, solvency, and other opinions, and related disclosure issues.
  • Represented numerous early stage and developing companies in connection with angel venture capital and private equity funding.
  • Advised angel investors in connection with various debt and equity financings.
  • Represented a telemedicine company in its financing and negotiation of license agreements.
  • Represented a real estate fund in connection with its formation and investments in several properties.
  • Represented a gaming and entertainment company in connection with its private placement financing, corporate governance matters, sale to a publicly traded U.K. company and subsequent growth transactions in the U.S.
  • Advised several French corporations in their U.S. operations, including their entry into the U.S. market.
  • Represented a publicly traded Canadian company in connection with several U.S. acquisitions.
  • Represented an Indian company in connection with its acquisition from a private equity fund of a life science company.
  • Represented a NYSE-listed company in its acquisition of one of the world’s leading car rental brands and a global travel technology solutions company.
  • Represented a privately held consumer products company in its acquisition by a NYSE-listed company.
  • Represented a privately held energy company in the sale of its gas recovery operations to quasi-governmental entity.
  • Represented a retail electronics chain in its sale to a private equity fund in an asset sale under Section 363 of the Bankruptcy Code.
  • Represented several boards of directors, audit committees, and compensation committees in connection with their SEC, NYSE, and Nasdaq reporting and compliance matters, including the restatement of annual reports on Form 10-K and the preparation of proxy materials.
  • Represented a health care company in the restructuring of $2.6 billion of its publicly traded debt.
  • Represented an electronic media company in a public offering of its securities listed on the Nasdaq.
  • Rated AV Preeminent by Martindale-Hubbell®
  • Best Lawyers in America®: Corporate Law (2016-2026)
  • Chambers USA: Corporate/M&A, Delaware (2016-2025)
  • Legal 500 United States for M&A/Corporate and Commercial: M&A: Middle-Market (Sub-$500M) (2022-2024) and Leading Lawyer (2025); M&A/Corporate and Commercial: Private Equity Buyouts: Middle-Market (Up to $500M) (2024-2025); and Finance: Capital Markets: Debt Offerings (2025)
  • Business Today: Top 10 Corporate/M&A Lawyers in Delaware (2023)
  • Member of the Alternative Entity Subcommittee of the Delaware State Bar Association’s Corporation Law Council, which is responsible for drafting amendments to the Delaware statutes governing limited liability companies, limited partnerships, and partnerships
  • President of the Delaware State Bar Association, 2010-2011
  • Co-chair of the DSBA’s Community Service Committee
  • Served on the board of the Delaware Lawyers Assistance Program, a member service of the DSBA that confidentially helps judges and attorneys with substance abuse, dependence and/or mental and physical health problems, and assists with the administration of the Race Judicata 5K road race, which benefits local charities
  • Served on the board of directors for the Junior Achievement of Delaware and has provided services to the Delaware College of Art and Design

Education

  • American University Washington College of Law, J.D., magna cum laude, 1996, note and comment editor, The Administrative Law Review
  • Trinity College, B.A., with honors, 1991, political science

Bar Admissions

  • Delaware

Court Admissions

  • U.S. District Court, District of Delaware